Lisinopril

Chemical formula: C₂₁H₃₁N₃O₅  Molecular mass: 405.488 g/mol  PubChem compound: 5362119

Therapeutic indications

Lisinopril is indicated for:

Hypertension

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 years old or older)

Hypertension

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Heart failure

Population group: only adults (18 years old or older)

Treatment of symptomatic heart failure.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Acute myocardial infarction

Population group: only adults (18 years old or older)

Short-term (6 weeks) treatment of haemodynamically stable patients within 24 hours of an acute myocardial infarction.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Renal disease in hypertensive patients with type 2 diabetes mellitus

Population group: only adults (18 years old or older)

Treatment of renal disease in hypertensive patients with type 2 diabetes mellitus and incipient nephropathy.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Lisinopril is contraindicated in the following cases:

Pregnancy

Pregnancy

Angioedema

at least one of
Angioedema
Angioedema caused by angiotensin-converting-enzyme inhibitor

Aliskiren in diabetes mellitus or renal impairment

Aliskiren and additionally at least one of
Diabetes mellitus



Renal failure stage 5: Kidney failure (GFR <15 mL/min/1.73 m2 or dialysis)

Sacubitril/valsartan

at least one of
Valsartan and sacubitril
Valsartan and additionally Sacubitril

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2021: ZESTRIL Tablet
Structured Product Labeling (SPL/PLR) 2020: ZESTRIL Tablet
Structured Product Labeling (SPL/PLR) 2020: PRINIVIL Tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈